Medicare (Traditional Part A & B) · restorative neurostimulation
✓ conditional · medicare rn
Criteria checklist
0 of 7 ticked- enumerated: yes
- covered:
- name: Chronic mechanical low back pain from lumbar multifidus dysfunction
- criteria:
- chronic lbp min months: 6
- etiology: mechanical/nociceptive LBP with multifidus dysfunction (ICD-10 M62.85); e.g., positive prone instability test
- conservative care failed: >=90 days refractory to medical management incl. physical therapy
- no radicular pain: yes
- no prior lumbar surgery: yes
- severity: moderate-to-severe pain/disability (e.g., VAS/ODI thresholds per ISASS)
- investigational:
- current radicular pain / radiculopathy
- prior lumbar spine surgery
- another dominant pain generator (e.g., stenosis, fracture, malignancy, infection)
- non-mechanical / inflammatory back pain
- required: yes
- min duration months: 3
- satisfied by:
- tried and failed >=90 days
- contraindicated
- modalities named:
- physical therapy
- pharmacologic
- activity modification
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
- required: no
- must clear: no
- note posture: not required
- applies: no
ReActiv8 (Mainstay Medical) restorative neurostimulation stimulates the L2 medial branch to rehabilitate the lumbar multifidus — mechanistically and by indication DISTINCT from pain-masking neurostimulation. No NCD and no IN/KY LCD govern it (WPS/CGS publish nothing), so Traditional Medicare adjudicates under §1862(a)(1)(A) reasonable-and-necessary. The criteria here are the de facto standard from FDA labeling and the ISASS 2025 guideline (chronic mechanical LBP >=6 months from multifidus dysfunction [ICD-10 M62.85], >=90 days failed conservative care, NO radicular pain, NO prior lumbar surgery) — not a binding policy. IMPORTANT: this shares CPT 64555/64590 with generic PNS but is a SEPARATE coverage cell (the documented PNS-vs-ReActiv8 split). Commercial payors frequently deem ReActiv8 investigational — flag when the commercial cells are built. Confirm current MAC posture before clinical use (needs_reverification). Criteria sources: ISASS 2025 guideline (IJSS 19(6):760); Mainstay Medical labeling; ReActiv8 trials.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. No NCD/LCD binds in IN/KY — documents to FDA labeling + ISASS 2025 under Medicare's reasonable-and-necessary standard. Distinct from generic PNS.
.REACTIV8MCARE Assessment: *** — chronic mechanical low back pain present >=6 months arising from lumbar multifidus dysfunction (ICD-10 M62.85), supported by *** (e.g., positive prone instability test / imaging). There is no radicular pain, no prior lumbar spine surgery, and no other dominant pain generator. Medical necessity under Medicare's reasonable-and-necessary standard (no NCD or LCD binds; documented to FDA labeling and the ISASS 2025 restorative-neurostimulation criteria): conservative and medical management has been tried and has failed over >=90 days — physical therapy, pharmacologic therapy, and activity modification: *** . Pain and disability are at threshold (VAS/ODI ***), and the etiology is mechanical (nociceptive). Alternative pain generators — stenosis, fracture, malignancy, infection, and inflammatory disease — are excluded. Plan: Implantation of the ReActiv8 restorative neurostimulation system (bilateral L2 medial branch leads 64555 x2 plus generator 64590). Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: no
- verified: no
- note: Not on the OPD prior-auth list (that list = implanted SPINAL neurostimulators). Confirm if hospital-outpatient.
Provenance
- authority:
- type: none
- id: not stated in the policy
- title: No NCD or IN/KY LCD; coverage adjudicated case-by-case under SSA §1862(a)(1)(A) (reasonable and necessary) by the local MAC
- applies because: No NCD for restorative neurostimulation; WPS (J8) and CGS (J15) publish no LCD (CMS MCD 'restorative neurostimulation' search = 0, verified 2026-06-28)
- peer lcds:
- source: https://www.ijssurgery.com/content/19/6/760
- effective: — · payor last reviewed: — · we verified: 2026-07-24 · v1
Change history
- 2026-07-24reactiv8/medicare: verified via MCP - still no restorative-neurostim LCD anywhere; R&N posture unchanged; last_verified 2026-07-24
7b1da3de18 - 2026-06-28Add ReActiv8 restorative neurostimulation x Medicare IN/KY cell (R&N)
582dbd4f48